Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclophosphamide (cytoxan) (1 trial)
pentostatin (nipent) (1 trial)
rituximab (rituxan) (1 trial)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Trials (1 total)
Trial APIs (3 total)